Browse
Submit Data
Databases
API
Help

Dataset Information

27 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Sotalol: acute effects on cardiovascular functions following oral administration in conscious, telemetered Cynomolgus primates.

ABSTRACT: N=4 male Conscious telemetered Cynomolgus monkeys, dosed with Sotalol successively per os at 5, 10 and 30 mg/kg. No PK performed. Parameters : haemodynamic parameters (SAP, DAP, MAP, pulse pressure, HR), lead II ECG (PR, QA, QRS, QT, QTcB, QTcV and QTcF intervals). Parameters were reported before administration then 1, 2, 3, 4, 5, 6, 8, 12, 16 and 20h after dosing. A baseline value (Pre-dose) was taken approximately 0.5 hours before dosing.

ORGANISM(S): Cynomolgus Monkeys

SUBMITTER:

PROVIDER: S-TQST87 | biostudies-other |

REPOSITORIES: biostudies-other

ACCESS DATA

Json Xml

Similar Datasets

Astemizole: Acute Effects on Cardiovascular Functions Following Oral Administration in Conscious, Telemetered Cynomolgus Monkeys (Macaca fascicularis)

Project description: Not available

| S-TQST85 | biostudies-other

Moxifloxacin: Acute Effects on Cardiovascular Functions Following Oral Administration in the Conscious Telemetered Beagle Dog

Project description: Not available

| S-TQST61 | biostudies-other

Sotalol: Cardiovascular Effects of sotalol in Conscious, Telemetered Beagle Dogs

Project description: Not available

| S-TQST63 | biostudies-other

Sotalol: cardiovascular effects in conscious, telemetered guinea pigs.

Project description: Not available

| S-TQST80 | biostudies-other

Sotalol: effects on arterial blood pressure, heart rate and lead II electrocardiogram (ECG) in conscious, telemetered Cynomolgus primates.

Project description: Not available

| S-TQST88 | biostudies-other

Sotalol: a cardiovascular safety pharmacology study using radiotelemetry in conscious beagle dogs following oral administration

Project description: Not available

| S-TQST64 | biostudies-other

Moxifloxacin: A Cardiovascular Safety Pharmacology Study Using Radiotelemetry in Conscious Cynomolgus Monkeys Following Oral Administration

Project description: Not available

| S-TQST84 | biostudies-other

Dose-response effects of sotalol on cardiovascular function in conscious, freely moving cynomolgus monkeys.

Project description:BACKGROUND AND PURPOSE: The non-selective beta-adrenoceptor antagonist, D,L-sotalol (sotalol) is commonly employed as a positive control during preclinical cardiovascular safety pharmacology testing, mainly because of its ability to prolong QT interval duration. However, no information appears in the literature, except in abstract form, regarding the dose-response effects of sotalol in unanesthetized monkeys. The current study was conducted to determine the dose- and plasma-response effects of orally administered sotalol on cardiovascular function in conscious non-human primates. EXPERIMENTAL APPROACH: Male cynomolgus monkeys were implanted with telemetry devices and the effects of sotalol hydrochloride (5, 10 and 30 mg kg(-1) of body weight, p.o.) on arterial blood pressure, heart rate, body temperature and electrocardiogram waveform were continuously monitored for 6 h after dosing. Blood was sampled for the measurement of plasma concentrations of sotalol. KEY RESULTS: Sotalol dose dependently decreased heart rate and prolonged RR, PR, QT and corrected QT intervals, while having little or no effects on the QRS complex, arterial pressure or body temperature, over the dose range tested. When the data were related to plasma concentrations of sotalol, it was clear that the cardiovascular effects occurred in a similar pattern and to a comparable degree as those reported in human studies. CONCLUSIONS AND IMPLICATIONS: The current study helps demonstrate the validity of utilizing telemetry-instrumented non-human primates for the cardiovascular safety pharmacology assessment of drugs prior to first-in-human testing, and its findings may serve as a reference source for the dose- and plasma-response effects of orally administered sotalol in conscious monkeys.

| S-EPMC2492091 | biostudies-other

The cardiovascular and pharmacokinetic profile of dofetilide in conscious telemetered beagle dogs and cynomolgus monkeys.

Project description:The effects of dofetilide were studied in monkeys and dogs. Pharmacokinetic data were generated together with the monitoring of cardiovascular changes in order to compare effects relative to human exposure.Beagle dogs and cynomolgus monkeys were telemetered to collect arterial blood pressure, heart rate and ECG for 6 h after selected oral doses of dofetilide. Pharmacokinetic parameters were determined for each dose.Dogs: increases in the QT(c) interval reached 56 ms in dogs dosed with 0.3 mg kg(-1) of dofetilide. Premature ventricular contractions and right bundle branch block were evident at this dose, without changes in cardiovascular parameters. The mean C(max) values were 3.35 and 60.15 ng mL(-1) at doses of 0.03 and 0.3 mg kg(-1), respectively. Monkeys: increases in QT(c) intervals reached 40-50 ms after 0.03 mg kg(-1). T-wave changes were observed after 0.03 mg kg(-1) without changes in cardiovascular parameters. The mean C(max) values following oral doses of 0.01 and 0.03 mg kg(-1) were 0.919 ng mL(-1) and 1.85 ng mL(-1), respectively.Despite dofetilide exposure comparable to that in humans, QT(c) responses in dogs were greater than those reported in humans. A comparable human dose used in the monkey achieved only half of the exposure but was associated with twofold greater increases in QT(c). Our data support the view that safety risk assessments of new drugs in animal models should ensure that the clinical therapeutic range of exposure is achieved and any untoward effects interpreted accordingly.

| S-EPMC2492096 | biostudies-other

Clozapine: cardiovascular Effects in Conscious, Telemetered Beagle Dogs

Project description: Not available

| S-TQST58 | biostudies-other